Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 5/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.52 |
| ▸ | HRH1 | P35367 | 4/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16227265 | 0.98 | NISCH (0.53) | NISCHHTR2ATAAR1HRH1CHRNB2 | |
| SCHEMBL22364526 | 0.83 | CHRNA7 (0.54) | NISCHHTR2ATAAR1CHRNB2CHRNA4 | |
| SCHEMBL3716302 | 0.83 | HRH1 (0.56) | NISCHHTR2ATAAR1HRH1CHRNB2 | |
| SCHEMBL1443955 | 0.79 | HRH1 (0.59) | NISCHHTR2ATAAR1HRH1CHRNB2 | |
| SCHEMBL8926699 | 0.79 | HTR2A (0.48) | HTR2AHRH1CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL119104 | 0.79 | HTR2A (0.48) | HTR2AHRH1CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL171013 | 0.79 | HTR2A (0.48) | HTR2AHRH1CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL19376998 | 0.78 | NISCH (0.52) | NISCHSLC6A4AOC3SLC6A3 | |
| SCHEMBL31016671 | 0.78 | AOC3 (0.47) | NISCHTAAR1SLC6A2SLC6A4AOC3 | |
| SCHEMBL29144175 | 0.78 | TAAR1 (0.54) | NISCHHTR2ATAAR1HRH1CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118791728-A | Clay stabilizer and preparation method thereof | 中石化西南石油工程有限公司 | 2024-10-18 | — | — | CN | claimed |
| WO-2016087603-A1 | PROCESS FOR PREPARING A MODIFIED NATURAL RUBBER BY MEANS OF A MODIFIER | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2016-06-09 | — | — | WO | claimed |
| EP-2547656-B1 | PYRIDINE AND PYRAZINE DERIVATIVE FOR THE TREATMENT OF CF | NOVARTIS AG (CH) | 2015-09-30 | — | — | EP | claimed |
| EP-2845593-A1 | Pyridine and pyrazine derivative for the treatment of chronic obstructive pulmonary disease | Novartis AG (CH) | 2015-03-11 | — | — | EP | claimed |
| EP-4463452-B1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC (US) | 2025-07-30 | — | — | EP | disclosed |
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | ANIMA BIOTECH INC. (US) | 2025-07-01 | — | — | US | disclosed |
| CN-119775151-A | Clay stabilizer and preparation method thereof | 中石化西南石油工程有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119775152-A | Clay stabilizer and preparation method thereof | 中石化西南石油工程有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2025-04-03 | — | — | US | disclosed |
| CN-118791728-B | Clay stabilizer and preparation method thereof | 中石化西南石油工程有限公司 | 2025-01-24 | — | — | CN | disclosed |
| EP-4463452-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| CN-118791728-A | Clay stabilizer and preparation method thereof | 中石化西南石油工程有限公司 | 2024-10-18 | — | — | CN | disclosed |
| WO-2005100305-A1 | ANDROGEN MODULATORS | WARNER-LAMBERT COMPANY LLC (US) | 2005-10-27 | — | — | WO | disclosed |
| WO-2005095343-A1 | DPP-IV INHIBITORS | SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH (CH) | 2005-10-13 | — | — | WO | disclosed |
| EP-0139661-A1 | SECONDARY AMINES | BEECHAM GROUP PLC (GB) | 1985-05-08 | — | — | EP | disclosed |
| WO-1984003278-A1 | SECONDARY AMINES | BEECHAM GROUP PLC (GB) | 1984-08-30 | — | — | WO | disclosed |
| US-4374779-A | Nitrosoamino-actonitriles | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-02-22 | — | — | US | disclosed |
| WO-1982001184-A1 | SYDNONE IMINE DERIVATIVES,INTERMEDIATES THEREFORE AND METHODS OF PREPARATION | AMERICAN HOME PROD (US) | 1982-04-15 | — | — | WO | disclosed |
| US-4324897-A | 1,2,3 Oxadiazolium salts | AMERICAN HOME PRODUCTS CORPORATION (US) | 1982-04-13 | — | — | US | disclosed |
| US-4289885-A | 3-[2-(Dimethylamino)-2-phenylethyl]N-[phenylamino)carbonyl]sydnone imine, a new central nervous system stimulant | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | MYC, MYCBP, MYCBP2 | NISCH 4235/4885HTR2A 4383/4885TAAR1 4805/4885 |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | MYC, MYCBP, MYCBP2 | NISCH 4235/4885HTR2A 4383/4885TAAR1 4805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.